---

Role of 2% rebamipide ophthalmic suspension in the management of dry eye disease

---

Original Article

Author Details : D N Prakash, Sujata Sajjan*, K Satish, Raghavendra R, Mohammed Abdul Kayoom

Volume : 5, Issue : 4, Year : 2019

Article Page : 461-465

https://doi.org/10.18231/j.ijceo.2019.110

Suggest article by email

Get Permission

---

Abstract

Objective: To study the therapeutic effects of 2% rebamipide ophthalmic suspension in dry eye disease.
Materials and Methods: It was Prospective study of 80 patients diagnosed with dry eye syndrome from
Jun 2016 to April 2017. After complete ophthalmic examination all were treated with 2% rebamipide
suspension. Dry eye-related Symptom Score, anterior segment examination with slit lamp, Tear Film
Break-Up Time, Fluorescein Ocular Surface Staining Score(FOS) & Schirmer test were used to collect
data from patients at baseline & at 2, 4, 8 & 12 week visits.
Results: Mean dry eye-related symptom score showed a significant improvement from baseline at 2, 4,
8 & 12 weeks (9.80, 7.20, 7.40 & 7.83 points). Median FOS also showed significant improvement from
baseline (3.0 points) at 2, 4, 8 & 12 weeks (2.0, 2.0, 1.0 & 1.0 points respectively). TBUT & Schirmer test
values also improved but were not significant after treatment.
Conclusion: 2% rebamipide ophthalmic suspension is an effective in treating dry eye. It helps in improving
both ocular & tear film stability.

Keywords: Dry eye syndrome, Tear film, Rebamipide, Mucin Secretion.

How to cite : Prakash D N, Sajjan S, Satish K, Raghavendra R, Kayoom M A, Role of 2% rebamipide ophthalmic suspension in the management of dry eye disease. Indian J Clin Exp Ophthalmol 2019;5(4):461-465

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.